메뉴 건너뛰기




Volumn 14, Issue 1, 2014, Pages

Adjuvant therapy after resection of colorectal liver metastases: The predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

Author keywords

5 FU; Colorectal cancer; FOLFIRI; FOLFOX; Leucovorin; Liver resection

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

EID: 84902006254     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-174     Document Type: Article
Times cited : (51)

References (44)
  • 1
    • 0025243470 scopus 로고
    • Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history
    • 10.1002/bjs.1800771115, 2253003
    • Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990, 77(11):1241-1246. 10.1002/bjs.1800771115, 2253003.
    • (1990) Br J Surg , vol.77 , Issue.11 , pp. 1241-1246
    • Scheele, J.1    Stangl, R.2    Altendorf-Hofmann, A.3
  • 2
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases
    • discussion 318-321, 10.1097/00000658-199909000-00004, 1420876, 10493478
    • Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230(3):309-318. discussion 318-321, 10.1097/00000658-199909000-00004, 1420876, 10493478.
    • (1999) Ann Surg , vol.230 , Issue.3 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3    Brennan, M.F.4    Blumgart, L.H.5
  • 5
    • 0031022988 scopus 로고    scopus 로고
    • Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
    • O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, Wieand HS. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997, 15(1):246-250.
    • (1997) J Clin Oncol , vol.15 , Issue.1 , pp. 246-250
    • O'Connell, M.J.1    Mailliard, J.A.2    Kahn, M.J.3    Macdonald, J.S.4    Haller, D.G.5    Mayer, R.J.6    Wieand, H.S.7
  • 6
    • 67650315187 scopus 로고    scopus 로고
    • Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial
    • 10.1200/JCO.2008.20.6771, 19451431
    • André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009, 27(19):3109-3116. 10.1200/JCO.2008.20.6771, 19451431.
    • (2009) J Clin Oncol , vol.27 , Issue.19 , pp. 3109-3116
    • André, T.1    Boni, C.2    Navarro, M.3    Tabernero, J.4    Hickish, T.5    Topham, C.6    Bonetti, A.7    Clingan, P.8    Bridgewater, J.9    Rivera, F.10    de Gramont, A.11
  • 10
    • 70349257296 scopus 로고    scopus 로고
    • Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases
    • 10.1002/jso.21346, 19572329
    • Merkel S, Bialecki D, Meyer T, Muller V, Papadopoulos T, Hohenberger W. Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol 2009, 100(5):349-357. 10.1002/jso.21346, 19572329.
    • (2009) J Surg Oncol , vol.100 , Issue.5 , pp. 349-357
    • Merkel, S.1    Bialecki, D.2    Meyer, T.3    Muller, V.4    Papadopoulos, T.5    Hohenberger, W.6
  • 11
    • 34547563877 scopus 로고    scopus 로고
    • Hepatic resection for colorectal metastases: value for risk scoring systems?
    • 10.1097/SLA.0b013e3180603039, 1933577, 17667495
    • Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, Nagorney DM. Hepatic resection for colorectal metastases: value for risk scoring systems?. Ann Surg 2007, 246(2):183-191. 10.1097/SLA.0b013e3180603039, 1933577, 17667495.
    • (2007) Ann Surg , vol.246 , Issue.2 , pp. 183-191
    • Zakaria, S.1    Donohue, J.H.2    Que, F.G.3    Farnell, M.B.4    Schleck, C.D.5    Ilstrup, D.M.6    Nagorney, D.M.7
  • 14
    • 70450245250 scopus 로고    scopus 로고
    • IVC CLAMP: infrahepatic inferior vena cava clamping during hepatectomy-a randomised controlled trial in an interdisciplinary setting
    • 10.1186/1745-6215-10-94, 2770522, 19825186
    • Rahbari NN, Zimmermann JB, Koch M, Bruckner T, Schmidt T, Elbers H, Reissfelder C, Weigand MA, Buchler MW, Weitz J. IVC CLAMP: infrahepatic inferior vena cava clamping during hepatectomy-a randomised controlled trial in an interdisciplinary setting. Trials 2009, 10:94. 10.1186/1745-6215-10-94, 2770522, 19825186.
    • (2009) Trials , vol.10 , pp. 94
    • Rahbari, N.N.1    Zimmermann, J.B.2    Koch, M.3    Bruckner, T.4    Schmidt, T.5    Elbers, H.6    Reissfelder, C.7    Weigand, M.A.8    Buchler, M.W.9    Weitz, J.10
  • 15
    • 79955452070 scopus 로고    scopus 로고
    • Postoperative course and clinical significance of biochemical blood tests following hepatic resection
    • 10.1002/bjs.7459, 21456090
    • Reissfelder C, Rahbari NN, Koch M, Kofler B, Sutedja N, Elbers H, Buchler MW, Weitz J. Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg 2011, 98(6):836-844. 10.1002/bjs.7459, 21456090.
    • (2011) Br J Surg , vol.98 , Issue.6 , pp. 836-844
    • Reissfelder, C.1    Rahbari, N.N.2    Koch, M.3    Kofler, B.4    Sutedja, N.5    Elbers, H.6    Buchler, M.W.7    Weitz, J.8
  • 16
    • 82955233165 scopus 로고    scopus 로고
    • The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients
    • 10.1245/s10434-011-1829-6, 21674269
    • Rahbari NN, Reissfelder C, Koch M, Elbers H, Striebel F, Buchler MW, Weitz J. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann Surg Oncol 2011, 18(13):3640-3649. 10.1245/s10434-011-1829-6, 21674269.
    • (2011) Ann Surg Oncol , vol.18 , Issue.13 , pp. 3640-3649
    • Rahbari, N.N.1    Reissfelder, C.2    Koch, M.3    Elbers, H.4    Striebel, F.5    Buchler, M.W.6    Weitz, J.7
  • 17
    • 60449093000 scopus 로고    scopus 로고
    • Meta-analysis of the clamp-crushing technique for transection of the parenchyma in elective hepatic resection: back to where we started?
    • 10.1245/s10434-008-0266-7, 19130140
    • Rahbari NN, Koch M, Schmidt T, Motschall E, Bruckner T, Weidmann K, Mehrabi A, Buchler MW, Weitz J. Meta-analysis of the clamp-crushing technique for transection of the parenchyma in elective hepatic resection: back to where we started?. Ann Surg Oncol 2009, 16(3):630-639. 10.1245/s10434-008-0266-7, 19130140.
    • (2009) Ann Surg Oncol , vol.16 , Issue.3 , pp. 630-639
    • Rahbari, N.N.1    Koch, M.2    Schmidt, T.3    Motschall, E.4    Bruckner, T.5    Weidmann, K.6    Mehrabi, A.7    Buchler, M.W.8    Weitz, J.9
  • 18
    • 41949114080 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection
    • 10.1002/bjs.6141, 18314921
    • Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall E, Schmidt J, Weitz J, Buchler MW. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg 2008, 95(4):424-432. 10.1002/bjs.6141, 18314921.
    • (2008) Br J Surg , vol.95 , Issue.4 , pp. 424-432
    • Rahbari, N.N.1    Wente, M.N.2    Schemmer, P.3    Diener, M.K.4    Hoffmann, K.5    Motschall, E.6    Schmidt, J.7    Weitz, J.8    Buchler, M.W.9
  • 19
    • 0028213430 scopus 로고
    • Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO)
    • Weh HJ, Wilke HJ, Dierlamm J, Klaassen U, Siegmund R, Illiger HJ, Schalhorn A, Kreuser ED, Hilgenfeld U, Steinke B. Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). Ann Oncol 1994, 5(3):233-237.
    • (1994) Ann Oncol , vol.5 , Issue.3 , pp. 233-237
    • Weh, H.J.1    Wilke, H.J.2    Dierlamm, J.3    Klaassen, U.4    Siegmund, R.5    Illiger, H.J.6    Schalhorn, A.7    Kreuser, E.D.8    Hilgenfeld, U.9    Steinke, B.10
  • 21
    • 0033198035 scopus 로고    scopus 로고
    • CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR
    • 10.1016/S0959-8049(99)00150-1, 10658525
    • André T, Louvet C, Maindrault-Goebel F, Couteau C, Mabro M, Lotz JP, Gilles-Amar V, Krulik M, Carola E, Izrael V, de Gramont A. CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR. Eur J Cancer 1999, 35(9):1343-1347. 10.1016/S0959-8049(99)00150-1, 10658525.
    • (1999) Eur J Cancer , vol.35 , Issue.9 , pp. 1343-1347
    • André, T.1    Louvet, C.2    Maindrault-Goebel, F.3    Couteau, C.4    Mabro, M.5    Lotz, J.P.6    Gilles-Amar, V.7    Krulik, M.8    Carola, E.9    Izrael, V.10    de Gramont, A.11
  • 22
    • 0022343067 scopus 로고
    • Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver
    • 10.1016/S0025-6196(12)60567-9, 3894814
    • O'Connell MJ, Adson MA, Schutt AJ, Rubin J, Moertel CG, Ilstrup DM. Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 1985, 60(8):517-520. 10.1016/S0025-6196(12)60567-9, 3894814.
    • (1985) Mayo Clin Proc , vol.60 , Issue.8 , pp. 517-520
    • O'Connell, M.J.1    Adson, M.A.2    Schutt, A.J.3    Rubin, J.4    Moertel, C.G.5    Ilstrup, D.M.6
  • 24
    • 33044488863 scopus 로고    scopus 로고
    • Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer
    • Lopez-Ladron A, Salvador J, Bernabe R. Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer. Proc Amer Soc Clin Oncol 2003, 22(373):1497.
    • (2003) Proc Amer Soc Clin Oncol , vol.22 , Issue.373 , pp. 1497
    • Lopez-Ladron, A.1    Salvador, J.2    Bernabe, R.3
  • 25
    • 33750962938 scopus 로고    scopus 로고
    • Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
    • 10.1200/JCO.2006.06.8353, 17075115
    • Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, Bugat R, Lazorthes F, Bedenne L. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006, 24(31):4976-4982. 10.1200/JCO.2006.06.8353, 17075115.
    • (2006) J Clin Oncol , vol.24 , Issue.31 , pp. 4976-4982
    • Portier, G.1    Elias, D.2    Bouche, O.3    Rougier, P.4    Bosset, J.F.5    Saric, J.6    Belghiti, J.7    Piedbois, P.8    Guimbaud, R.9    Nordlinger, B.10    Bugat, R.11    Lazorthes, F.12    Bedenne, L.13
  • 28
    • 1842569206 scopus 로고    scopus 로고
    • A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    • Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004, 22(1):23-30.
    • (2004) J Clin Oncol , vol.22 , Issue.1 , pp. 23-30
    • Goldberg, R.M.1    Sargent, D.J.2    Morton, R.F.3    Fuchs, C.S.4    Ramanathan, R.K.5    Williamson, S.K.6    Findlay, B.P.7    Pitot, H.C.8    Alberts, S.R.9
  • 29
    • 0032585197 scopus 로고    scopus 로고
    • Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
    • 10.1016/S0140-6736(98)03085-2, 9807986
    • Rougier P, Van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R, Navarro M, Morant R, Bleiberg H, Wils J, Awad L, Herait P, Jacques C. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998, 352(9138):1407-1412. 10.1016/S0140-6736(98)03085-2, 9807986.
    • (1998) Lancet , vol.352 , Issue.9138 , pp. 1407-1412
    • Rougier, P.1    Van Cutsem, E.2    Bajetta, E.3    Niederle, N.4    Possinger, K.5    Labianca, R.6    Navarro, M.7    Morant, R.8    Bleiberg, H.9    Wils, J.10    Awad, L.11    Herait, P.12    Jacques, C.13
  • 32
    • 79955040540 scopus 로고    scopus 로고
    • Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer
    • 10.1200/JCO.2010.33.6297, 21383294
    • Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K, Schmoll HJ. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011, 29(11):1465-1471. 10.1200/JCO.2010.33.6297, 21383294.
    • (2011) J Clin Oncol , vol.29 , Issue.11 , pp. 1465-1471
    • Haller, D.G.1    Tabernero, J.2    Maroun, J.3    de Braud, F.4    Price, T.5    Van Cutsem, E.6    Hill, M.7    Gilberg, F.8    Rittweger, K.9    Schmoll, H.J.10
  • 33
    • 70449105423 scopus 로고    scopus 로고
    • A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
    • 10.1093/annonc/mdp236, 19567451
    • Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C, Shacham-Shmueli E, Rivera F, Kwok-Keung Choi C, Santoro A. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 2009, 20(12):1964-1970. 10.1093/annonc/mdp236, 19567451.
    • (2009) Ann Oncol , vol.20 , Issue.12 , pp. 1964-1970
    • Ychou, M.1    Hohenberger, W.2    Thezenas, S.3    Navarro, M.4    Maurel, J.5    Bokemeyer, C.6    Shacham-Shmueli, E.7    Rivera, F.8    Kwok-Keung Choi, C.9    Santoro, A.10
  • 34
    • 34247550169 scopus 로고    scopus 로고
    • Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents
    • discussion 761-753, 10.1016/j.jamcollsurg.2006.12.036, 17481478
    • Parks R, Gonen M, Kemeny N, Jarnagin W, D'Angelica M, DeMatteo R, Garden OJ, Blumgart LH, Fong Y. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 2007, 204(5):753-761. discussion 761-753, 10.1016/j.jamcollsurg.2006.12.036, 17481478.
    • (2007) J Am Coll Surg , vol.204 , Issue.5 , pp. 753-761
    • Parks, R.1    Gonen, M.2    Kemeny, N.3    Jarnagin, W.4    D'Angelica, M.5    DeMatteo, R.6    Garden, O.J.7    Blumgart, L.H.8    Fong, Y.9
  • 36
    • 84855758951 scopus 로고    scopus 로고
    • Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases
    • 10.1016/j.surg.2011.07.020, 21982065
    • Maithel SK, Gonen M, Ito H, Dematteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D'Angelica MI. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery 2012, 151(2):162-170. 10.1016/j.surg.2011.07.020, 21982065.
    • (2012) Surgery , vol.151 , Issue.2 , pp. 162-170
    • Maithel, S.K.1    Gonen, M.2    Ito, H.3    Dematteo, R.P.4    Allen, P.J.5    Fong, Y.6    Blumgart, L.H.7    Jarnagin, W.R.8    D'Angelica, M.I.9
  • 37
    • 67649234580 scopus 로고    scopus 로고
    • A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential
    • 10.1053/j.gastro.2009.03.041, 19328798
    • Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 2009, 137(1):165-175. 10.1053/j.gastro.2009.03.041, 19328798.
    • (2009) Gastroenterology , vol.137 , Issue.1 , pp. 165-175
    • Fritzmann, J.1    Morkel, M.2    Besser, D.3    Budczies, J.4    Kosel, F.5    Brembeck, F.H.6    Stein, U.7    Fichtner, I.8    Schlag, P.M.9    Birchmeier, W.10
  • 38
    • 77950458280 scopus 로고    scopus 로고
    • Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer
    • 10.1053/j.gastro.2010.01.008, 20100481
    • Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, Diener MK, Buchler MW, Koch M, Weitz J. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 2010, 138(5):1714-1726. 10.1053/j.gastro.2010.01.008, 20100481.
    • (2010) Gastroenterology , vol.138 , Issue.5 , pp. 1714-1726
    • Rahbari, N.N.1    Aigner, M.2    Thorlund, K.3    Mollberg, N.4    Motschall, E.5    Jensen, K.6    Diener, M.K.7    Buchler, M.W.8    Koch, M.9    Weitz, J.10
  • 40
    • 77149163487 scopus 로고    scopus 로고
    • KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases
    • 10.1245/s10434-009-0605-3, 19727962
    • Nash GM, Gimbel M, Shia J, Nathanson DR, Ndubuisi MI, Zeng ZS, Kemeny N, Paty PB. KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases. Ann Surg Oncol 2010, 17(2):572-578. 10.1245/s10434-009-0605-3, 19727962.
    • (2010) Ann Surg Oncol , vol.17 , Issue.2 , pp. 572-578
    • Nash, G.M.1    Gimbel, M.2    Shia, J.3    Nathanson, D.R.4    Ndubuisi, M.I.5    Zeng, Z.S.6    Kemeny, N.7    Paty, P.B.8
  • 41
    • 84865020846 scopus 로고    scopus 로고
    • CXCR4 Expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases
    • Yopp AC, Shia J, Butte JM, Allen PJ, Fong Y, Jarnagin WR, Dematteo RP, D'Angelica MI. CXCR4 Expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. Ann Surg Oncol 2011, 19(Suppl 3):S339-S346.
    • (2011) Ann Surg Oncol , vol.19 , Issue.SUPPL 3
    • Yopp, A.C.1    Shia, J.2    Butte, J.M.3    Allen, P.J.4    Fong, Y.5    Jarnagin, W.R.6    Dematteo, R.P.7    D'Angelica, M.I.8
  • 42
    • 84855528629 scopus 로고    scopus 로고
    • Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis
    • 10.1200/JCO.2011.36.9504, 22124103
    • Rahbari NN, Bork U, Motschall E, Thorlund K, Buchler MW, Koch M, Weitz J. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 2012, 30(1):60-70. 10.1200/JCO.2011.36.9504, 22124103.
    • (2012) J Clin Oncol , vol.30 , Issue.1 , pp. 60-70
    • Rahbari, N.N.1    Bork, U.2    Motschall, E.3    Thorlund, K.4    Buchler, M.W.5    Koch, M.6    Weitz, J.7
  • 43
    • 80051549354 scopus 로고    scopus 로고
    • Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases
    • 10.1245/s10434-011-1761-9, 21598056
    • Rahbari NN, Reissfelder C, Muhlbayer M, Weidmann K, Kahlert C, Buchler MW, Weitz J, Koch M. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases. Ann Surg Oncol 2011, 18(8):2182-2191. 10.1245/s10434-011-1761-9, 21598056.
    • (2011) Ann Surg Oncol , vol.18 , Issue.8 , pp. 2182-2191
    • Rahbari, N.N.1    Reissfelder, C.2    Muhlbayer, M.3    Weidmann, K.4    Kahlert, C.5    Buchler, M.W.6    Weitz, J.7    Koch, M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.